Gedeon Richter UK

Showing 1 posts of 1 posts found.

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026
Manufacturing and Production Gedeon Richter UK, Neurology

Gedeon Richter UK has announced its acquisition of full marketing and distribution rights to Reagila (cariprazine), a schizophrenia treatment, from …

The Gateway to Local Adoption Series

Latest content